Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher Scientific stock heads into October 21 results after a 2.27 percent drop

Published on 10/06/2026 at 17:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Thermo Fisher Scientific stock posted Q2 adjusted EPS of USD 6.03 on July 23, 2026, up 13 percent. Full-year adjusted EPS guidance stands at USD 24.93-25.33 ahead of the October 21 results date.

Aquarellbild eines gläsernen Forschungscampus an einem Fluss mit herbstlichen Bäumen — Aquarellmalerei symbolisiert Thermo Fisher Sci. US8835561023 mit gläsernem Forschungscampus entlang eines ruhigen Flusses im Herbst, Illustration mit AI erstellt.

Thermo Fisher Scientific (ISIN US8835561023) was trading at USD 661.40 on the NYSE at 11:38 a.m. EDT on October 6, 2026, down 2.27 percent from the prior close. The company is scheduled to release its third-quarter results on October 21, giving the market a defined checkpoint after a strong first half.

October 21 is the next checkpoint

According to Thermo Fisher Scientific in its September 28, 2026 release, third-quarter financial results will be published before the market opens on October 21, 2026, followed by a conference call at 7:00 a.m. ET. The date matters because the company raised its full-year outlook after the second quarter.

The current price is 4.75 percent below the October 6 intraday high of USD 694.33, while the session low was USD 654.51. That spread leaves the next earnings report as the clearest test of whether the recent earnings improvement can support the valuation.

Q2 growth lifted the outlook

In the July 23, 2026 earnings call, Fortune reported that second-quarter revenue rose 10 percent to USD 11.99 billion and adjusted EPS increased 13 percent to USD 6.03. Adjusted operating income grew 15 percent to USD 2.73 billion, and the adjusted operating margin expanded by 90 basis points to 22.8 percent.

The company raised fiscal 2026 revenue guidance to USD 47.4 billion-48.1 billion and adjusted EPS guidance to USD 24.93-25.33. The range implies 9-11 percent adjusted EPS growth over 2025, while first-half organic growth was 3 percent and management expected 4 percent for the second half.

Targets stay below the latest quote

According to MarketScreener, the consensus rating was Buy from 29 analysts, with an average target of USD 649.96, a high target of USD 780.00 and a low target of USD 520.00. Goldman Sachs raised its target from USD 650.00 to USD 780.00 while maintaining Buy on September 21, 2026, according to Yahoo Finance.

Stock trades below its yearly high

Thermo Fisher Scientific stock was last at USD 661.40 on the NYSE on October 6, 2026 at 11:38 a.m. EDT. Its 52-week range was USD 435.27-694.33, and its market capitalization was USD 244.6 billion, making the October 21 report the next major company-specific valuation test.